IL-13 facilitates hepatic steatosis and fibrosis, the latter through mechanisms including the stimulation of TGF-β1 gene expression [29] and through activation of the JAK-STAT-6 pathway, in turn results in the production of CCL11, an eosinophil chemotactic protein [30]. The gene discussed is CCL11; the disease is fatty liver disease.